G6PD and malaria: Susceptibility of G6PD deficient individuals to haemolysis caused by anti-malarial drugs such as primaquine and other 8-aminoquinolines is a concern for worldwide efforts for malaria eradication, given the geographical overlap between malaria-endemic areas and those populations with high prevalence of G6PD deficiency [12,13,27].